Phathom Pharmaceuticals Cash Flow Statement (2018-2026) | PHAT

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-63.72M-35.81M-40.70M-50.92M-51.08M-67.72M-37.83M-46.29M-43.05M-65.06M-82.81M-91.44M-118.69M-74.50M-94.29M-83.42M-55.21M-10.15M-47.97M-28.00M
Depreciation and Depletion (Quarter)
0.13M0.11M0.10M0.10M0.20M0.10M0.10M0.10M0.10M
Share-based Compensation (Quarter)
4.42M4.34M5.78M5.88M5.82M6.66M7.05M7.25M6.14M24.58M5.63M6.10M5.63M6.69M5.54M8.27M9.30M5.61M20.10M18.10M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.24M0.47M0.12M0.90M-0.08M-0.54M
Cash from Operations (Quarter)
-29.07M-41.26M-44.76M-25.72M-35.02M-41.04M-39.67M-22.20M-31.91M-43.80M-69.02M-70.72M-63.57M-63.46M-84.93M-62.73M-14.12M-5.00M-15.65M-1.93M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
2.39M0.51M0.52M0.53M0.56M0.50M0.50M0.27M0.54M0.57M0.47M0.50M0.59M0.63M0.70M0.73M0.78M0.81M0.84M0.91M
Depreciation & Amortization (CF) (Quarter)
0.13M0.14M0.13M0.15M0.17M0.17M0.15M0.12M0.12M0.18M0.21M0.20M0.19M0.19M0.18M0.17M0.16M0.13M0.11M0.11M
Change in Working Capital
Change in Receivables (Quarter)
1.64M2.24M7.00M10.18M17.75M-2.43M14.89M4.53M22.34M2.60M16.70M
Change in Inventory (Quarter)
0.11M9.33M0.42M-0.27M0.42M5.58M12.33M1.85M-0.40M-2.00M-0.67M3.96M
Change in Accured Expenses (Quarter)
-0.09M0.26M0.00M2.86M-2.66M0.17M0.06M0.02M0.03M6.31M0.16M3.51M-3.30M34.56M0.09M5.32M1.11M-6.41M-3.12M23.40M
Other Working Capital Changes (Quarter)
-0.97M2.57M4.38M-5.79M-0.89M4.15M5.14M-1.51M4.18M0.25M-0.45M2.75M-0.52M5.89M-7.81M1.56M-1.39M2.12M-6.92M-0.13M
Investing Activities
Capital Expenditures (Quarter)
0.05M0.04M0.07M-0.05M0.61M-0.51M3.45M-2.06M0.04M-0.03M0.12M-0.12M0.12M-0.06M1.17M0.06M
Cash from Investing Activities (Quarter)
-0.01M-0.10M-0.07M-0.43M-0.13M-0.41M-0.21M-0.01M-0.94M-0.47M-0.04M-0.05M-0.04M-0.01M-0.02M-0.10M-0.03M-0.09M-0.06M-0.04M
Financing Activities
Other financing activities (Quarter)
1.26M0.16M0.01M172.55M0.28M1.30M0.08M0.29M1.26M0.59M3.55M
Cash from Financing Activities (Quarter)
44.03M0.16M24.60M14.07M141.50M0.01M211.99M9.90M24.77M122.06M26.05M0.08M-0.27M-0.10M66.64M3.55M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
24.60M14.07M0.00M38.70M
Additional items
Change in Cash (Quarter)
14.95M-41.20M-44.82M69.30M-10.55M-41.45M-25.81M119.30M-32.84M167.72M-59.16M-46.00M58.44M-37.41M-84.95M-62.75M-14.41M-5.18M50.93M1.58M
Free Cash Flow (Quarter)
-29.12M-41.31M-44.82M-25.66M-35.63M-40.53M-39.67M-22.20M-35.36M-41.74M-69.06M-70.69M-63.69M-63.33M-84.93M-62.84M-14.05M-6.17M-15.71M-1.93M
Net Cash Flow (Quarter)
14.95M-41.20M-44.82M-26.14M-10.55M-41.45M-25.81M119.30M-32.84M167.72M-59.16M-46.00M58.44M-37.41M-84.95M-62.75M-14.41M-5.18M50.93M1.58M